Skip to main content
Clinical Trials/CTRI/2023/06/054257
CTRI/2023/06/054257
Not yet recruiting
未知

An intervention based Prospective study to assess the efficacy of CognitiveBotics software (an indigenously developed AI based software) in providing the integrated interventions in different domains - the social or emotional, language or communication, cognitive and movement or physical development of children diagnosed with Autism Spectrum Disorder. - NI

CognitiveBotics Technologies Private Limited0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: F840- Autistic disorder
Sponsor
CognitiveBotics Technologies Private Limited
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
CognitiveBotics Technologies Private Limited

Eligibility Criteria

Inclusion Criteria

  • 1\. Children diagnosed ASD using assessment scales such as
  • Childhood Autism Rating Scales (CARS)
  • 2\. Children with 2 to 18 years
  • 3\. Children with associated comorbidities will be included as long as the child is able to use the tool.
  • 4\. Ability to understand and respond to instructions given in English
  • 5\. Access to a device on which the software can be accessed using internet connection.
  • 6\. Parents who have consented for their child to use the software.

Exclusion Criteria

  • 1\. Children with intellectual disability with IQ score \<50\.
  • 2\. Parents who are not willing to consent to the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials